John Bothmer

Title: John Bothmer: Innovator in Pharmaceutical Dosage Forms

Introduction

John Bothmer is a notable inventor based in Heerlen, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents, Bothmer's work has the potential to impact the way medications are administered.

Latest Patents

Bothmer's latest patents focus on pharmaceutical dosage forms that incorporate 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. These formulations are designed for administration twice daily, once daily, or less frequently, and include a physiologically acceptable salt of the compound. This innovation aims to enhance the effectiveness and convenience of medication delivery.

Career Highlights

Throughout his career, John Bothmer has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Bothmer has collaborated with notable colleagues such as Nadja Gruening and Marc Schiller. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

John Bothmer's contributions to pharmaceutical dosage forms demonstrate his commitment to improving medication administration. His innovative patents and collaborations highlight his role as a key figure in the pharmaceutical industry.